Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Open Access
- 24 June 2016
- journal article
- practice guideline
- Published by Springer Science and Business Media LLC in Gastric Cancer
- Vol. 20 (1), 1-19
- https://doi.org/10.1007/s10120-016-0622-4
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelinesGastric Cancer, 2013
- Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 studyGastric Cancer, 2012
- Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysisGastric Cancer, 2011
- Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)Gastric Cancer, 2011
- Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancerGastric Cancer, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancerGastric Cancer, 2009
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Capecitabine and Oxaliplatin for Advanced Esophagogastric CancerNew England Journal of Medicine, 2008
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006